Mohammed, M., Asrat, D., Woldeamanuel, Y. & Demissie, A. Prevalence of group B Streptococcus colonization among pregnant women attending antenatal clinic of Hawassa Health Center, Hawassa, Ethiopia. Ethiop. J. Health Dev. 26(1), 36–42 (2012).
Morgan, J. A., Zafar, N. & Cooper, D. B. Group B Streptococcus and Pregnancy. Treasure Island (FL) ineligible companies. Disclosure: Nowera Zafar declares no relevant financial relationships with ineligible companies. Disclosure: Danielle Cooper declares no relevant financial relationships with ineligible companies.: StatPearls Publishing.
Melin, P. Neonatal group B streptococcal disease: From pathogenesis to preventive strategies. Clin. Microbiol. Infect. 17(9), 1294–1303 (2011).
Jannati, E. et al. Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran. J. Microbiol. 4(3), 130 (2012).
Ueno, H. et al. Characterization of group B streptococcus isolated from women in Saitama City, Japan. Jpn. J. Infect. Dis. 65(6), 516–521 (2012).
Hanna, M. & Noor, A. Streptococcus Group B. Treasure Island (FL) ineligible companies. Disclosure: Asif Noor declares no relevant financial relationships with ineligible companies.: StatPearls Publishing.
Mengist, A., Kannan, H. & Abdissa, A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res. Notes 9(1), 351 (2016).
Borghesi, A., Stronati, M. & Fellay, J. Neonatal group B streptococcal disease in otherwise healthy infants: Failure of specific neonatal immune responses. Front. Immunol. 8, 215 (2017).
Shiferawu, S., Mekonen, M., Baza, D. & Lera, T. Prevalence of group b streptococcus, its associated factors and antimicrobial susceptibility pattern among pregnant women attending antenatal care at Arbaminch Hospital, South Ethiopia. Am. J. Health Res. 7(6), 104–115 (2019).
Miselli, F. et al. Transmission of group B Streptococcus in late-onset neonatal disease: A narrative review of current evidence. Ther. Adv. Infect. Dis. 9, 1–14 (2022).
Shirazi, M. et al. The prevalence of group B streptococcus colonization in Iranian pregnant women and its subsequent outcome. Int. J. Fertil. Steril. 7(4), 267–270 (2014).
Jin, G. et al. Maternal and neonatal outcomes of Group B Streptococcus colonization: A retrospective study. BMC Infect. Dis. 25(1), 94 (2025).
Husen, O. et al. Prevalence, antimicrobial susceptibility pattern and associated factors of group B Streptococcus among pregnant women attending antenatal Care at Bule Hora University Teaching Hospital, Southern Ethiopia. Infect. Drug Resist. 16, 4421–4433 (2023).
Ying, Q., Wang, S., Lou, X., Ding, J. & Ding, J. Burden and risk factors of invasive group B Streptococcus disease among neonates in a Chinese maternity hospital. BMC Infect. Dis. 19(1), 123 (2019).
Serra, G. et al. Group B streptococcus colonization in pregnancy and neonatal outcomes: A three-year monocentric retrospective study during and after the COVID-19 pandemic. Ital. J. Pediatr. 50(1), 175 (2024).
Fairlie, T., Zell, E. R. & Schrag, S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet. Gynecol. 121(3), 570–577 (2013).
Le Doare, K. et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: Systematic review. Clin. Infect. Dis. 65(suppl_2), S143–S151 (2017).
Costa HdPF, BRITO A: Prevenção da doença perinatal pelo estreptococo do grupo B. Manual da Sociedade Brasileira de Pediatria, 1–18 (2011).
Kimura, K. et al. High frequency of fluoroquinolone-and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J. Antimicrob. Chemother. 68(3), 539–542 (2013).
Desravines, N. et al. Intrapartum group B streptococcus antibiotic prophylaxis in penicillin allergic pregnant women. AJP Rep. 9(3), e238–e243 (2019).
De Francesco, M. A., Caracciolo, S., Gargiulo, F. & Manca, N. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy. Eur. J. Clin. Microbiol. Infect. Dis. 31(8), 1741–1747 (2012).
Fröhlicher, S. et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med. Wkl. 144(1112), w13935 (2014).
Khan, M. A., Faiz, A. & Ashshi, A. M. Maternal colonization of group B streptococcus: Prevalence, associated factors and antimicrobial resistance. Ann. Saudi Med. 35(6), 423–427 (2015).
Back, E. E., O’Grady, E. J. & Back, J. D. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York Hospital. Antimicrob. Agents Chemother. 56(2), 739–742 (2012).
Abarzúa, F. et al. Prevalencia de portación vaginal-anal de Streptococcus agalactiae en el tercer trimestre de gestación y susceptibilidad a macrólidos y lincosamidas, en mujeres embarazadas de Clínica Alemana Temuco, Chile. Rev. Chilena Infectol. 31(3), 305–308 (2014).
Dutra, V. G. et al. Streptococcus agalactiae in Brazil: Serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect. Dis. 14(1), 323 (2014).
Melo, S. C. et al. Antimicrobial susceptibility of Streptococcus agalactiae isolated from pregnant women. Rev. Inst. Med. Trop. Sao Paulo 58, 83 (2016).
Girma, W., Yimer, N., Kassa, T. & Yesuf, E. Group B Streptococcus recto-vaginal colonization in near-term pregnant women, Southwest Ethiopia. Ethiop. J. Health Sci. 30(5), 687–696 (2020).
Wayne, P. Performance standards for antimicrobial susceptibility testing. In CLSI Supplements M00130th ed Clinical and Laboratory Standards Institute (2020).
Zhang, Z. Model building strategy for logistic regression: purposeful selection. Ann. Transl. Med. 4(6), 111 (2016).
Alemseged, G. et al. Isolation and anti-microbial susceptibility pattern of group B Streptococcus among pregnant women attending antenatal clinics in Ayder Referral Hospital and Mekelle Health Center, Mekelle, Northern Ethiopia. BMC. Res. Notes 8(1), 518 (2015).
Assefa, S., Desta, K. & Lema, T. Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia. BMC Pregnancy Childbirth 18(1), 1–9 (2018).
Gizachew, M. et al. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: Alarming for prophylaxis. Ann. Clin. Microbiol. Antimicrob. 18(1), 3 (2019).
Mengist, H. M., Zewdie, O., Belew, A. & Dabsu, R. Prevalence and drug susceptibility pattern of group B Streptococci (GBS) among pregnant women attending antenatal care (ANC) in Nekemte Referral Hospital (NRH), Nekemte, Ethiopia. BMC Res. Notes 10(1), 1–6 (2017).
Anosike, I., Ebana, R., Edet, U., Egbomuche, R. & Victory, A. Prevalence of Streptococcus agalactiae among women resident in Calabar, Cross River State, Nigeria. Asian J. Res. Med. Pharm. Sci. 2, 1–7 (2017).
Sadaka, S. M., Aly, H. A., Meheissen, M. A., Orief, Y. I. & Arafa, B. M. Group B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt. Alex. J. Med. 54(1), 69–76 (2018).
Wang, P. et al. Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China. PLoS ONE 10(3), e0120035 (2015).
Shin, A. et al. Group B Streptococcus detection rate and clindamycin resistance among reproductive-age women in Korea during 2003–2022. J. Korean Med. Sci. 40(15), e29 (2025).
Scheftelowitz Cohen, R., Chodik, G. & Eisenberg, V. H. Re-evaluating Perinatal Group B Streptococcal screening in Israel—Is it time for a change in policy?. Prev. Med. 153, 106716 (2021).
Islam, N., Furuya-Kanamori, L., Mahmood, S. & Thalib, L. Prophylactic antibiotics for preventing genital tract infection in women undergoing surgical procedures for incomplete abortion: A systematic review and meta-analysis of randomised controlled trials. BJOG Int. J. Obst. Gynaecol. 128(8), 1273–1281 (2021).
Esmaon, R., Lim, B. K., Gan, F., Hamdan, M. & Tan, P. C. Sexual activity, vaginal symptoms, maternal perineal hygiene behavior, and constipation on ano-vaginal colonization of group B streptococcus in near term pregnancy. BMC Pregnancy Childbirth 24(1), 461 (2024).
Brokaw, A., Furuta, A., Dacanay, M., Rajagopal, L. & Adams Waldorf, K. M. Bacterial and host determinants of group B streptococcal vaginal colonization and ascending infection in pregnancy. Front. Cell. Infect. Microbiol. 11, 720789 (2021).
Sri-Budayanti, N. & Hariyasa-Sanjaya, N. Group-B streptococcus in pregnant women: Prevalence of colonization and sensitivity pattern in denpasar during June 2007 May 2008. Bali Med. J. 2(1), 17–20 (2013).
Dashtizade, M., Zolfaghari, M. R., Yousefi, M. & Nazari-Alam, A. Antibiotic susceptibility patterns and prevalence of Streptococcus agalactiae rectovaginal colonization among pregnant women in Iran. Rev. Bras. Ginecol. Obstet. 42(8), 454–459 (2020).
Bolukaoto, J. Y. et al. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res. Notes 8(1), 364 (2015).
Nabil, A., Esleem, S. E. & Elmanama, A. A. Prevalence of group B streptococcus colonization among pregnant women in Gaza strip, Palestine. IUG J. Nat. Stud. 25(3), 1–12 (2017).
Fantahun, Y., Sebre, S., Seman, A. & Kumbi, S. Magnitude of maternal vaginal colonization of Group B streptococcus and neonatal transmission in pregnant women during labor and delivery at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop. Med. J. 58, 105–113 (2020).
Mudzana, R., Mavenyengwa, R. T. & Gudza-Mugabe, M. Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples. BMC Infect. Dis. 21(1), 125 (2021).
Gebretekle, G. B. et al. Half of prescribed antibiotics are not needed: A pharmacist-led antimicrobial stewardship intervention and clinical outcomes in a referral hospital in Ethiopia. Front. Public Health 8, 109 (2020).
MaHAaCA EF: A practical guide to antimicrobial stewardship program in Ethiopian hospitals. Addis Ababa, Ethiopia (2018).
Ibrahim, R. A. et al. Antimicrobial resistance surveillance in Ethiopia: Implementation experiences and lessons learned. Afr. J. Lab. Med. 7(2), 770 (2018).
World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022 (World Health Organization, 2022).
Gebremeskel, T. K., Zeleke, T. A., Mihret, A. & Tikue, M. D. Prevalence and antibiotic susceptibility pattern of Streptococcus agalactiae among pregnant women at Adigrat Zonal Hospital and Adigrat Health Center, Tigray, Ethiopia. J. Gynecol. Obstet. 3(2), 29–35 (2015).
Jisuvei, S. C., Osoti, A. & Njeri, M. A. Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; A cross-sectional study. BMC Infect. Dis. 20, 1–9 (2020).
Ayenew, W. et al. Prevalence and predictors of self-medication with antibiotics in Ethiopia: A systematic review and meta-analysis. Antimicrob. Resist. Infect. Control 13(1), 61 (2024).
